The $2.3 billion Intelerad deal is the company's largest software acquisition since spinning off from GE, accelerating a pivot from hardware vendor to digital health platform
March 18th, 2026: GE HealthCare completes Intelerad acquisitionNew here? Follow stories to track developments over time. Create a free account to get updates when stories you care about change.
GE HealthCare has spent more than $2.5 billion on imaging software acquisitions in the three years since becoming an independent company — and the largest piece just fell into place. On March 18, the company completed its $2.3 billion purchase of Intelerad, a Montreal-based firm whose cloud software manages roughly 80 billion medical images across 2,500 healthcare organizations. Intelerad's strength in outpatient clinics and ambulatory care fills a gap in GE HealthCare's portfolio, which has historically centered on hospital-based imaging hardware like MRI and CT scanners.
GE HealthCare now pairs the industry's largest imaging hardware base—more than four million devices—with a leading cloud-native software platform for storing, viewing, and analyzing images. The company plans to triple its cloud-enabled products by 2028 and grow digital revenues 50% above its 2024 baseline of $1.2 billion.
The roughly 2,500 clinics already using Intelerad's software must now decide whether integration improves care or locks them into a single vendor.
No questions yet — be the first to ask.
A healthcare worker operates an MRI scanner with a patient in a medical facility.
A patient consults with a technician in a modern MRI room, highlighting advanced healthcare facilities.
A person lying in an MRI machine during a medical screening in a healthcare facility.
Peter Arduini's Takeaways from GE HealthCare's 2Q Earnings ...
GE HealthCare
GE Healthcare CEO Peter Arduini talks AI investments
CNBC Television
GE Health CEO on Sutter Health Deal, AI in Care Delivery ...
Bloomberg Podcasts
Images from Openverse under Creative Commons licenses. Videos from YouTube.
Curated perspectives — historical figures and your fellow readers.
Fictional AI pastiche — not real quote.
"Four million devices and now the software to hold every last image hostage — that is not a healthcare company, that is a toll road with a stethoscope. I built my empire the same way: own the track, and every man who wishes to travel must pay my price."
Fictional AI pastiche — not real quote.
"How refreshing — a company that collects medical images the way the rest of us collect regrets: compulsively, expensively, and always convinced that this next acquisition will finally make us whole."
Exploring all sides of a story is often best achieved with Play.
Your progress in this debate will be lost.
Choose one persona for each side of the debate
Choose personas with different perspectives for a more dynamic debate.
Select debater for this side:
No debate personas available right now.
Select debater for this side:
No debate personas available right now.
Make your prediction before the referee scores
Pick the question both personas must answer in the final round
Debate Oracle! You called every round!
Sharp Instincts! You know your debaters!
The Coin Flip Strategist! Perfectly balanced!
The Contrarian! Bold predictions!
Inverse Genius! Try betting the opposite next time!
GE HealthCare is one of the three largest medical imaging companies globally, with roughly $19.6 billion in annual revenue and more than 51,000 employees across 160 countries.
Intelerad provides cloud-based medical imaging software — including picture archiving, diagnostic viewing, and workflow tools — to approximately 2,500 healthcare organizations managing roughly 80 billion images.
TA Associates is a global growth-focused private equity firm that held a majority stake in Intelerad from July 2022 until the GE HealthCare acquisition closed.
January 2023 March 2026
GE HealthCare closed its $2.3 billion purchase of Intelerad after clearing all regulatory reviews. Intelerad will operate within GE HealthCare's Imaging business, serving customers across the United States, Canada, the United Kingdom, and Oceania.
Kevin A. Lobo, chair and chief executive of orthopedic device maker Stryker Corporation, was appointed to GE HealthCare's board of directors, adding medical technology M&A expertise ahead of the Intelerad integration.
The Australian Competition and Consumer Commission initiated a review of the Intelerad acquisition, given both companies' presence in the Oceania market. The review was ultimately cleared without conditions.
GE HealthCare announced a definitive agreement to acquire Intelerad from TA Associates and Hg Capital for $2.3 billion in cash, its largest software acquisition to date. The company projected Intelerad's first full-year revenue at approximately $270 million.
At the annual meeting of the Radiological Society of North America, Intelerad debuted InteleGence, an open platform for integrating third-party AI algorithms directly into radiology workflows.
GE HealthCare acquired MIM Software, a provider of medical imaging analysis and AI solutions for radiation oncology and diagnostics, for roughly $290 million — its second major software deal since independence.
GE HealthCare completed its purchase of Caption Health, a San Mateo company whose artificial intelligence software guides clinicians through cardiac ultrasound scans. The deal signaled the company's post-spin-off appetite for AI-focused acquisitions.
GE completed the spin-off of GE HealthCare Technologies as a standalone public company trading on the Nasdaq, part of GE's three-way breakup. The new company had roughly $18 billion in revenue and 51,000 employees.
3 moments from history that rhyme with this story — and how they unfolded.
Siemens Healthineers, GE HealthCare's chief rival, paid $16.4 billion for Varian Medical Systems, a leading cancer treatment technology company. At the time, it was the largest acquisition in the medical device industry's history. The deal gave Siemens a vertically integrated oncology platform spanning imaging, diagnosis, and radiation therapy.
Siemens gained a commanding position in cancer care workflows and added roughly $3 billion in annual recurring revenue from Varian's service contracts.
The deal set the template for medical imaging companies using mega-acquisitions to move beyond hardware into integrated care platforms, directly inspiring GE HealthCare's software acquisition strategy.
GE HealthCare's Intelerad purchase follows the playbook Siemens pioneered: use a large acquisition to transform from an equipment seller into a platform company. The key difference is that GE chose cloud software over treatment hardware as its expansion vector.
IBM paid $1 billion for Merge Healthcare, a medical imaging software company managing roughly 7.5 billion medical images. IBM planned to feed Merge's imaging data into its Watson artificial intelligence platform to create an AI-powered radiology assistant. At the time, IBM projected Watson Health would become a multibillion-dollar business.
IBM gained a significant footprint in medical imaging IT and announced partnerships with major hospital systems to pilot AI-assisted diagnosis.
Watson Health largely failed to deliver on its AI promises. IBM sold the division to Francisco Partners in January 2022 for roughly $1 billion — a fraction of the estimated $4 billion IBM had invested overall in Watson Health. The unit was rebranded as Merative.
The IBM-Merge deal is the most direct cautionary precedent for GE HealthCare's strategy. Both involve a large technology company acquiring a medical imaging software firm to build an AI-enhanced platform. GE HealthCare's advantages over IBM include an existing healthcare customer base, deep domain expertise, and 72 FDA-cleared AI tools — assets IBM lacked.
Oracle Corporation paid $28.3 billion for Cerner Corporation, one of the two dominant electronic health records companies in the United States. Oracle CEO Larry Ellison argued that moving Cerner's systems to Oracle's cloud infrastructure would modernize healthcare IT. The deal was Oracle's largest acquisition ever.
Oracle gained immediate access to healthcare systems representing roughly a quarter of U.S. hospital beds and began migrating Cerner customers to cloud infrastructure.
The integration proved slow and contentious, with some health systems reporting disruptions during cloud migration. The deal showed both the enormous opportunity and significant friction involved when technology companies try to modernize entrenched healthcare IT systems.
Like Oracle with electronic health records, GE HealthCare is betting that cloud migration of entrenched healthcare IT systems represents a generational opportunity. The Oracle-Cerner experience illustrates both the scale of the prize and the difficulty of executing cloud transitions in risk-averse healthcare environments.